PCI Pharma Services Executive and Leadership Team

November, 2026

Leadership Overview

PCI Pharma Services has 7 executives leading key functions including financial strategy, global operations, clinical quality, manufacturing development, and clinical trial services.

Focused on advancing global healthcare, PCI Pharma Services delivers innovative sterile and non-sterile solutions while maintaining rigorous regulatory compliance across 38 GMP facilities worldwide.

Leadership Roles at PCI Pharma Services

  • Chief Financial Officer - Tom DeWeerdt
  • Chief Operating Officer - Gil Valadez
  • Chief Operating Officer, Clinical Quality Documents - Ann Hudson
  • Chief Operating Officer, Clinical Quality Documents - Laila Rubi
  • President, Development & Manufacturing - Michelle Logan
  • President, Clinical Trial Services - Brian Keesee
  • President - Halley Liu
  • Tom DeWeerdt - Chief Financial Officer

    Tom DeWeerdt, the Chief Financial Officer at PCI Pharma Services, directs all global fiscal strategy and capital allocation. Overseeing financial planning and analysis, the Chief Financial Officer ensures the organization maintains robust liquidity to support the expansion of sterile and non-sterile manufacturing capabilities. This leadership role involves managing complex budgetary requirements across 38 GMP facilities to drive long-term profitability. By optimizing cost structures and capital investments, Tom DeWeerdt directly impacts the ability of the company to scale clinical trial services and commercial packaging technology. DeWeerdt secures the financial foundation necessary for sustained growth in the competitive CDMO landscape. Through rigorous oversight of fiscal performance, the Chief Financial Officer aligns resource distribution with the overarching mission of delivering life-changing therapies to patients worldwide while maintaining strict adherence to international regulatory standards.
    Tom DeWeerdt

    Gil Valadez - Chief Operating Officer

    Gil Valadez, the Chief Operating Officer at PCI Pharma Services, manages the daily execution of global manufacturing operations and supply chain logistics. Overseeing the integration of sterile and non-sterile service lines, the Chief Operating Officer ensures operational excellence across the entire product lifecycle. This leadership role involves coordinating cross-functional teams to maintain high-quality output within the 38 GMP facilities. By streamlining production workflows and enhancing facility efficiency, Gil Valadez directly impacts the speed and reliability of commercial packaging technology delivery. Valadez drives continuous improvement initiatives to meet the evolving needs of pharmaceutical clients. Through the synchronization of global manufacturing assets, the Chief Operating Officer supports the company commitment to ingenuity and innovation, ensuring that every clinical and commercial project meets the highest levels of quality and regulatory compliance required for patient safety.
    Gil Valadez

    Ann Hudson - Chief Operating Officer, Clinical Quality Documents

    Ann Hudson, the Chief Operating Officer, Clinical Quality Documents at PCI Pharma Services, architects the framework for clinical documentation and regulatory compliance protocols. Overseeing the integrity of quality systems, the Chief Operating Officer, Clinical Quality Documents ensures that all clinical trial data meets stringent international standards. This leadership role involves managing the documentation lifecycle to support seamless regulatory submissions for pharmaceutical partners. By implementing advanced quality management systems, Ann Hudson directly impacts the reliability of clinical trial services. Hudson drives the standardization of quality processes across global operations to mitigate risk and ensure patient safety. Through the meticulous oversight of clinical quality documentation, the Chief Operating Officer, Clinical Quality Documents facilitates the successful transition of therapies from development to commercialization, reinforcing the reputation of the company as a trusted partner in the global healthcare ecosystem.

    Laila Rubi - Chief Operating Officer, Clinical Quality Documents

    Laila Rubi, the Chief Operating Officer, Clinical Quality Documents at PCI Pharma Services, directs the strategic implementation of quality assurance programs for clinical trial documentation. Overseeing the audit readiness of clinical records, the Chief Operating Officer, Clinical Quality Documents ensures that all data handling processes align with global regulatory requirements. This leadership role involves collaborating with internal teams to refine quality control measures for complex clinical trial services. By fostering a culture of compliance, Laila Rubi directly impacts the efficiency of the product development lifecycle. Rubi manages the oversight of quality documentation systems to support the rapid advancement of life-changing therapies. Through the rigorous monitoring of quality metrics, the Chief Operating Officer, Clinical Quality Documents maintains the high standards of excellence expected by clients, ensuring that every clinical project adheres to the precise specifications required for successful regulatory approval.

    Michelle Logan - President, Development & Manufacturing

    Michelle Logan, the President, Development & Manufacturing at PCI Pharma Services, leads the strategic growth of sterile and non-sterile manufacturing capabilities. Overseeing the development of innovative service solutions, the President, Development & Manufacturing ensures that the company remains at the forefront of pharmaceutical manufacturing technology. This leadership role involves managing the expansion of production capacity across global facilities to meet increasing market demand. By driving technical ingenuity, Michelle Logan directly impacts the ability of the organization to support clients from early-stage development through commercialization. Logan coordinates with cross-functional leaders to align manufacturing output with client timelines and quality expectations. Through the oversight of development and manufacturing operations, the President, Development & Manufacturing advances the mission of the company to improve patient lives by delivering high-quality, reliable pharmaceutical solutions that meet the complex needs of the global healthcare industry.
    Michelle Logan

    Brian Keesee - President, Clinical Trial Services

    Brian Keesee, the President, Clinical Trial Services at PCI Pharma Services, directs the global strategy for clinical trial support and supply chain management. Overseeing the execution of complex clinical programs, the President, Clinical Trial Services ensures that pharmaceutical clients receive seamless support throughout the entire trial lifecycle. This leadership role involves managing the logistics of clinical packaging and distribution to ensure timely delivery of therapies to patients. By optimizing clinical trial workflows, Brian Keesee directly impacts the success of drug development initiatives. Keesee drives the integration of innovative technology to enhance the efficiency and accuracy of clinical services. Through the oversight of clinical trial operations, the President, Clinical Trial Services supports the commitment of the company to advancing healthcare, ensuring that every clinical project is executed with the highest levels of quality, ingenuity, and regulatory compliance.

    Halley Liu - President

    Halley Liu, the President at PCI Pharma Services, oversees the overarching strategic direction and operational performance of the entire organization. Driving the mission to deliver life-changing therapies, the President ensures that all business units remain aligned with the core values of intelligence, ingenuity, and innovation. This leadership role involves coordinating with the executive team to expand the global footprint of the company across 38 GMP facilities. By fostering a culture of collaboration, Halley Liu directly impacts the ability of the organization to provide comprehensive solutions in sterile and non-sterile services. Liu manages the long-term growth strategy to ensure the company maintains its position as a leader in the CDMO industry. Through the oversight of all corporate functions, the President supports the commitment to improving patient lives by ensuring that every service provided meets the highest standards of quality and regulatory excellence.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding PCI Pharma Services Top Executives and Leadership Team

    Who leads PCI Pharma Services?
    PCI Pharma Services is led by Tom DeWeerdt (Chief Financial Officer), along with executives such as Gil Valadez (Chief Operating Officer) and Ann Hudson (Chief Operating Officer, Clinical Quality Documents).
    Who is part of PCI Pharma Services’s executive team?
    The executive team of PCI Pharma Services includes leaders such as Tom DeWeerdt (Chief Financial Officer), Gil Valadez (Chief Operating Officer), Ann Hudson (Chief Operating Officer, Clinical Quality Documents) and other senior executives.
    How many executives does PCI Pharma Services have?
    PCI Pharma Services has 7 executives leading key business areas.
    What roles are included in PCI Pharma Services’s leadership team?
    The leadership team of PCI Pharma Services includes roles such as Chief Financial Officer, Chief Operating Officer, Chief Operating Officer, Clinical Quality Documents, Chief Operating Officer, Clinical Quality Documents, President, Development & Manufacturing.